Letters Antidepressant use and FDA warnings Proxy for suicide attempts was inappropriate in study of changes in antidepressant use after FDA warnings BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g5644 (Published 09 October 2014) Cite this as: BMJ 2014;349:g5644 Article Related content Metrics Responses Peer review Related articles No related articles found. See more Johnson & Johnson is ordered to pay $1bn over faulty hip implants BMJ December 06, 2016, 355 i6551; DOI: https://doi.org/10.1136/bmj.i6551 A question of evidence BMJ November 24, 2016, 355 i6316; DOI: https://doi.org/10.1136/bmj.i6316 A national prescription drug line could help to assess the non-medical use of prescription drugs BMJ November 16, 2016, 355 i6084; DOI: https://doi.org/10.1136/bmj.i6084 Spice and all things nasty: the challenge of synthetic cannabinoids BMJ October 24, 2016, 355 i5639; DOI: https://doi.org/10.1136/bmj.i5639 Drug related deaths in England and Wales BMJ October 17, 2016, 355 i5259; DOI: https://doi.org/10.1136/bmj.i5259 Cited by... Reservations about study on antidepressant use by young people and suicidal behaviour after FDA warningsFulltext PDF Authors' reply to Olfson and Schoenbaum, Nardo, Bartlett, Moore, Case, Gotzsche, and Barber and colleaguesFulltext PDF
